Analysis of a Novel Homeobox gene in CV Development

CV 发育中的新型同源盒基因分析

• 批准号: 9062130
• 负责人: Jonathan A. Epstein
• 金额: $ 4.47万
• 依托单位: UNIVERSITY OF PENNSYLVANIA
• 依托单位国家: 美国
• 财政年份: 2003
• 资助国家: 美国
• 起止时间: 2003-09-01 至 2018-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9062130
• 关键词: Adult; Alleles; Amino Acids; Animals; Binding; Biochemical; Brain; Cardiac; Cardiac Myoblasts; Cardiac Myocytes; Cells; ChIP-seq; Clinic; Clustered Regularly Interspaced Short Palindromic Repeats; Collaborations; Complex; DNA; Data; Development; Dose; Embryo; Embryonic Development; Endothelial Cells; Enhancers; Epitopes; Funding; Genes; Genetic Transcription; Genomics; Grant; Hair follicle structure; Health; Heart; Heart failure; Helix-Turn-Helix Motifs; Histone Acetylation; Histones; Homeobox Genes; Homeodomain Proteins; Human; In Vitro; Intestines; Laboratories; Legal patent; Mediator of activation protein; Methylation; Multipotent Stem Cells; Mus; Muscle Cells; Myocardial; Myocardial Infarction; Myocardial rupture; Myocardium; Patients; Phenotype; Population; Pregnancy; Private Sector; Publications; Recruitment Activity; Regulation; Relative (related person); Role; Rupture; Site; Smooth Muscle; Smooth Muscle Myocytes; Sorting - Cell Movement; Staging; Stem cells; Structure; Technology; Testing; Time; Tissues; Tomatoes; Translating; Translations; Work; adapter protein; alpha helix; cell type; cofactor; homeodomain; in vivo; induced pluripotent stem cell; loss of function; multipotent cell; novel; precursor cell; progenitor; protein complex; regenerative therapy; stem; stem cell population

DESCRIPTION (provided by applicant): This is a competitive renewal application to study the role an atypical homeodomain protein called Hopx that is expressed in the heart. My laboratory discovered Hopx about 10 years ago, and we have shown that it functions, at least in part, by recruiting histone deacetylases (HDACs) to transcription complexes. This work, funded by this grant, led to numerous high-profile publications, patent applications, and it has spurred our efforts in collaboration with the private sector to translate the findings and bring new therapies for heart failure to the clinic. Our mechanistic studies have shown that Hopx does not bind directly to DNA, but that it is a component of cardiac repressor complexes. Hopx is expressed by cardiac progenitor cells at early time-points of murine embryogenesis, just after Nkx2-5, at ~E8.0, and inactivation of Hopx leads to partially penetrant embryonic lethality and thin myocardium. Cardiac progenitors that express Nkx2-5 are multipotent and can produce myocardial, smooth muscle or endothelial lineages. However, Hopx-expressing progenitors are committed to the myocardial lineage. Our data suggest that fate decisions of cardiac precursor cells are biased by Hopx dose and activity. We hypothesize that Hopx is an extremely early (perhaps the earliest) marker of committed myocardial cells and that Hopx functions to reinforce the myocardial lineage choice by recruiting HDACs and other transcription cofactors to repress critical mediators of alternate fates and of the multipotent state. Understanding how myocardial fate decisions are executed and reinforced will inform our ability to enhance regenerative therapies and instruct stem and progenitor cells to produce functional myocardium.

描述（由申请人提供）：这是一项竞争性更新申请，旨在研究心脏中表达的一种名为Hopx的非典型同源结构域蛋白的作用。我的实验室在大约10年前发现了Hopx，我们已经证明它的功能，至少部分是通过招募组蛋白脱乙酰酶（HDAC）到转录复合物中来实现的。这项工作，由这笔赠款资助，导致了许多备受瞩目的出版物，专利申请，并促使我们努力与私营部门合作，翻译研究结果，并为临床带来新的心力衰竭疗法。我们的机制研究表明，Hopx不直接与DNA结合，但它是心脏阻遏复合物的一个组成部分。在小鼠胚胎发生的早期时间点，紧接在Nkx 2 -5之后，在~E8.0，由心脏祖细胞表达Hopx，并且Hopx的失活导致部分穿透性胚胎致死和薄心肌。表达Nkx 2 -5的心脏祖细胞是多能的，并且可以产生心肌、平滑肌或内皮谱系。然而，表达Hopx的祖细胞致力于心肌谱系。我们的数据表明，心脏前体细胞的命运决定受到Hopx剂量和活性的影响。我们假设，Hopx是一个非常早期（也许是最早的）标记的承诺心肌细胞和Hopx功能，以加强心肌谱系的选择，招募HDAC和其他转录辅因子抑制关键介质的交替命运和多能状态。了解心肌命运决定是如何执行和加强的，将有助于我们提高再生治疗的能力，并指导干细胞和祖细胞产生功能性心肌。